Panacea Biotec gets USFDA nod to launch Prasugrel tablets Ruby Khatun Khatun25 Oct 2017 10:17 AM ISTNew Delhi: Drug firm Panacea Biotec said it has received final approval from the US health regulator to launch generic Prasugrel tablets, used for...
AstraZeneca gets FDA approval for BYDUREON BCise Injectable medicine for Type-2 Diabetes Ruby Khatun Khatun25 Oct 2017 9:47 AM ISTWILMINGTON, Del.: AstraZeneca announced that the US Food and Drug Administration (FDA) has approved BYDUREON® BCise™ (exenatide extended-release)...
FDA warns Meridian of violations for lead-testing devices Ruby Khatun Khatun25 Oct 2017 9:30 AM ISTThe U.S. Food and Drug Administration (FDA) said on Monday it issued a warning letter to Meridian Bioscience Inc’s unit for several federal law...
Smith and Nephew to buy Rotation Medical for up to 210 million dollars Ruby Khatun Khatun25 Oct 2017 9:12 AM ISTLONDON: Medical technology group Smith and Nephew, which has been urged by activist investor Elliott Management to shed some operations according to...
Fleming Labs Nawabpet facility comes under USFDA scanner Ruby Khatun Khatun24 Oct 2017 11:00 AM ISTNew Delhi: The US health regulator has issued an import alert for the drugs and drug products manufactured by Hyderabad-based Fleming Laboratories at...
GSK wins US shingles vaccine approval, UK nod for gene therapy Ruby Khatun Khatun24 Oct 2017 10:30 AM ISTLONDON: GlaxoSmithKline (GSK) has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which the British...
Novartis gets FDA breakthrough status for Tafinlar, Mekinist combination Ruby Khatun Khatun24 Oct 2017 10:00 AM ISTZURICH: Novartis on Monday said the U.S. Food and Drug Administration has granted breakthrough therapy status to the combination of Tafinlar and...
AstraZeneca among backers as Swiss cancer biotech raises 200 million dollars Ruby Khatun Khatun24 Oct 2017 9:30 AM ISTLONDON: An unlisted Swiss biotech company focused on developing “armed antibodies” to fight cancer has raised $200 million in a funding round backed...
Merck cyber attack may cost insurers 275 million dollars: Verisks PCS Ruby Khatun Khatun23 Oct 2017 9:57 AM ISTNEW YORK: Insurers could pay $275 million to cover the insured portion of drugmaker Merck & Co's loss from a cyber attack in June, according to a...
Britain backs GSK gene therapy for BUBBLE BOY syndrome Ruby Khatun Khatun23 Oct 2017 9:32 AM ISTGlaxoSmithKline's (GSK) gene therapy for the so-called "bubble boy" disease was approved by Britain's healthcare cost watchdog NICE, despite a price...
DBV Technologies peanut allergy drug fails key study Ruby Khatun Khatun23 Oct 2017 9:15 AM ISTDBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study, sending its...
Anpac Bio surpasses 50,000 case study milestone Liquid Biopsy Pioneer serving individual, medical, insurance and corporate customers Ruby Khatun Khatun23 Oct 2017 9:00 AM ISTSACRAMENTO, California: Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company, announced...
